ENDRA Life Sciences Inc. (NDRA)

Listed in the US · Manufacturing · Electromedical and electrotherapeutic apparatus

$4.88

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $4.88 on 29 Oct 2026. The share price traded between $2.96 and $6.95 (intraday) over the last 12 months.

The closes as a table

Date	Close

Key figures

1-year range (intraday)

Low $2.96High $6.95

Market cap$7Mlast close × shares

Return on equity−311.1%year to Dec 2025

Debt to equity0.00year to Dec 2025

Dividend yieldnonelast 12 months

Price trend

Stage 3 (topping): the 150-day average has stopped rising, or the price is below a rising one, for 10 trading days.
Supertrend (10, 3): the price has closed below the line for 12 trading days.

Revenue and profit

RevenueNet profit$ million

-20-1001020

Dec 2021Net profit 11.23Dec ’21

Dec 2022Net profit 13.18Dec ’22

Dec 2023Net profit -10.06Dec ’23

Dec 2024Net profit -11.51Dec ’24

Dec 2025Net profit -7.03Dec ’25

Year	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net profit	11.23	13.18	-10.06	-11.51	-7.03
Borrowings	0.55	0.03	0.03	0.00	0.00

$ million.

Recent filings

Questions about ENDRA Life Sciences Inc.

What is ENDRA Life Sciences Inc.'s market value?

ENDRA Life Sciences Inc.'s market value is $7M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with NDRA

Free to start: test a trading idea on NDRA's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Test a strategy on NDRA Open the full deep dive

Same industry

The largest companies in the same industry (Electromedical and electrotherapeutic apparatus), by market value.

Medtronic plc (MDT)LivaNova PLC (LIVN)Integer Holdings Corp (ITGR)Axogen, Inc. (AXGN)TransMedics Group, Inc. (TMDX)Conmed Corp (CNMD)Ceribell, Inc. (CBLL)InMode Ltd. (INMD)CapsoVision, Inc (CV)Electromed, Inc. (ELMD)Edap TMS SA (FOCL)Vivani Medical, Inc. (VANI)

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

Last close: the closing price on the date shown. The page follows the market's close; it doesn't show prices during the session. A price older than the market's latest close, or a last trade that isn't a close, is labelled as the last price, with the session it is from.
1-year range: the lowest and highest prices traded during the sessions of the last year (intraday), so they can lie outside the closing prices.
Market cap: the last close times the shares in issue. It is n/a when it doesn't agree with the company's own reported figures (for example a depositary share counted as an ordinary share).
P/E: the last close divided by earnings per share over the last four reported quarters, the profit that belongs to the company's shareholders per share, as the company reports it. So P/E can differ from market cap divided by the net profit shown (a different share count, or the profit before minority interests; where they differ by more than 10%, a note under the figures gives both). A company that reports only once a year has its latest year's earnings, and the P/E names that year; when that year ended more than about 15 months before the close, P/E is n/a. A loss has no P/E. Above 1,000 it is n/a.
EBITDA margin: operating profit before depreciation, interest and tax (and before other income), as a share of revenue in the latest reported year, the table's last column.
Net margin: net profit as a share of revenue in the latest reported period. Return on equity, the margins and debt to equity each use inputs from that one year; if one input is missing for it, the figure is n/a. When that year ended more than about 15 months before the close, they are n/a too.
Dividend yield: every dividend per share with an ex-date in the 12 months to the last close, special dividends included, as a share of that close. n/a when the company's dividends couldn't be read.
n/m: not meaningful. A margin or return beyond ±1,000% comes from revenue or equity near zero, so it is not shown as a number.